Clinical Trials Browser

OTHER × Head and Neck Neoplasms × Lapatinib × Clear all

NCT01612351 2026-03-17

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

Phase 2 Completed

40 enrolled 20 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01044433 2020-03-19

Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck

Phase 2 Completed

44 enrolled 11 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00490061 2017-03-06

Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy

Phase 2 Terminated

17 enrolled 7 charts

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01184482 2013-10-31

TYKERB-ITUX 1

Phase 1 Completed

GastrointestinalHead & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Colorectal Neoplasms